Table 5.

Distribution of the detectable prostate cancers in terms of Gleason score

PSA (ng/ml)	No. of PC	Gleason < 7	Gleason = 7	Gleason > 7
0–4	21	10 (47.6%)	4 (19.1%)	7 (33.3%)
4–10	61	22 (36.1%)	19 (31.1%)	20 (32.8%)
10–20	123	43 (35.0%)	42 (34.1%)	38 (30.9%)
20–100	146	30 (20.5%)	43 (29.5%)	73 (50.0%)
≥ 100	87	2 (2.3%)	21 (24.1%)	64 (73.6%)
Total	438	107 (24.4%)	129 (29.5%)	202 (46.1%)

PSA prostate-specific antigen, PC prostate cancer